We are live on ! Find out more
DC

Diametric Capital Portfolio holdings

AUM $385M
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+42.93%
1 Year Est. Return
+31.69%
3 Year Est. Return
+134.95%
5 Year Est. Return
+239.28%
10 Year Est. Return
AUM
$130M
AUM Growth
+$48M
Cap. Flow
+$20.3M
Cap. Flow %
15.57%
Top 10 Hldgs %
26.17%
Holding
203
New
85
Increased
34
Reduced
37
Closed
45

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79M
2
EBAY icon
eBay
EBAY
+$1.77M
3
ERIC icon
Ericsson
ERIC
+$1.76M
4
CMCSA icon
Comcast
CMCSA
+$1.68M
5
CHDN icon
Churchill Downs
CHDN
+$1.63M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.75%
2 Healthcare 20.2%
3 Industrials 15.39%
4 Technology 12.47%
5 Energy 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$127B
$999K 0.77%
+16,982
New +$1.02M
MNTV
52
DELISTED
Momentive Global Inc. Common Stock
MNTV
$967K 0.74%
+41,072
New +$749K
ALXN
53
DELISTED
Alexion Pharmaceuticals
ALXN
$964K 0.74%
+8,589
New +$912K
CCS icon
54
Century Communities
CCS
$2B
$960K 0.74%
31,300
-5,877
-16% -$140K
POOL icon
55
Pool Corp
POOL
$6.7B
$956K 0.73%
3,516
-88
-2% -$20.4K
MRK icon
56
Merck
MRK
$324B
$955K 0.73%
+12,944
New +$974K
PCRX icon
57
Pacira BioSciences
PCRX
$1.02B
$950K 0.73%
18,110
+2,680
+17% +$112K
SGI
58
Somnigroup International
SGI
$15.1B
$938K 0.72%
52,132
+19,480
+60% +$279K
SRPT icon
59
Sarepta Therapeutics
SRPT
$1.66B
$926K 0.71%
5,774
+2,645
+85% +$360K
RH icon
60
RH
RH
$3.3B
$924K 0.71%
3,711
-6,628
-64% -$1.2M
COLL icon
61
Collegium Pharmaceutical
COLL
$1.14B
$904K 0.69%
51,634
-4,265
-8% -$83.5K
BRK.B icon
62
Berkshire Hathaway Class B
BRK.B
$1.07T
$842K 0.65%
4,718
+2,254
+91% +$412K
CMRX
63
DELISTED
Chimerix, Inc.
CMRX
$842K 0.65%
+271,730
New +$703K
ICAD
64
DELISTED
iCAD Inc
ICAD
$832K 0.64%
83,235
+14,020
+20% +$151K
PRNB
65
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$694K 0.53%
11,611
+219
+2% +$13.5K
DELL icon
66
Dell
DELL
$283B
$674K 0.52%
+24,221
New +$544K
ZYME icon
67
Zymeworks
ZYME
$1.68B
$653K 0.5%
18,110
-3,359
-16% -$124K
DHT icon
68
DHT Holdings
DHT
$2.97B
$625K 0.48%
121,839
+44,053
+57% +$281K
BMRN icon
69
BioMarin Pharmaceuticals
BMRN
$11.5B
$622K 0.48%
5,042
+1,099
+28% +$109K
GDX icon
70
VanEck Gold Miners ETF
GDX
$23B
$564K 0.43%
15,363
-30,384
-66% -$999K
MRTN icon
71
Marten Transport
MRTN
$1.33B
$555K 0.43%
33,107
-38,164
-54% -$600K
ARCT icon
72
Arcturus Therapeutics
ARCT
$157M
$536K 0.41%
11,478
-39,543
-78% -$1.36M
PRKS icon
73
United Parks & Resorts
PRKS
$2.11B
$533K 0.41%
35,982
+25,114
+231% +$370K
EQH icon
74
Equitable Holdings
EQH
$13.1B
$528K 0.4%
+27,385
New +$489K
PRPL icon
75
Purple Innovation
PRPL
$33.2M
$526K 0.4%
+1,168
New +$368K

Similar funds

Diametric Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Diametric Capital held 203 positions worth $130M, up 58% from $82.5M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Diametric Capital deployed $20.3M of net new capital in Q2 2020, opening 85 new positions and adding to 34 existing holdings. Its largest new stake was Invesco S&P 500 Low Volatility ETF: 66,078 shares worth $3.28M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Churchill Downs, an estimated $1.63M trimmed.

  • Diametric Capital's largest Q2 2020 buy was Invesco S&P 500 Low Volatility ETF: 66,078 shares worth $3.28M.
  • Diametric Capital added most to Tesla in Q2 2020, an estimated $1.77M increase.
  • Diametric Capital's biggest Q2 2020 reduction was Churchill Downs, cutting an estimated $1.63M.
  • Diametric Capital fully exited State Street SPDR S&P 500 ETF Trust in Q2 2020, selling an estimated $1.79M.
  • Diametric Capital's ten largest holdings make up 26% of its $130M portfolio in Q2 2020.
  • Diametric Capital opened 85 new positions and closed 45 in Q2 2020.
  • Diametric Capital's portfolio value rose 58% quarter-over-quarter to $130M.

Based on Diametric Capital's 13F filing for Q2 2020, filed 14 Aug 2020.